Corbus Pharma (CRBP) – Management Comments
-
Corbus Pharma (CRBP) Reports Q4; Provides Corporate Updates
-
Corbus Pharma (CRBP) Reports Complete Enrollment in NIH-Sponsored Phase 2 Study of Lenabasum for Treatment of Systemic Lupus Erythematosus
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to CRBP Stock Lookup